Cargando…

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study

Detalles Bibliográficos
Autores principales:	Chouchana, Laurent, Preta, Laure-Hélène, Tisseyre, Mylène, Terrier, Benjamin, Treluyer, Jean-Marc, Montastruc, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907730/ https://www.ncbi.nlm.nih.gov/pubmed/33647327 http://dx.doi.org/10.1016/j.kint.2021.02.015

Ejemplares similares

Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
por: Touafchia, Anthony, et al.
Publicado: (2021)

Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019
por: Montastruc, François, et al.
Publicado: (2020)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)

Risque de vascularites systémiques après une vaccination anti-SARS-CoV-2 à base d’ARN : une étude de pharmacovigilance
por: Mettler, C., et al.
Publicado: (2022)

Isolated noncaseating granulomatous inflammation of the lacrimal sac masquerading as a malignancy
por: Singh, Swati, et al.
Publicado: (2022)

Sarcoidosis, Mycobacterium paratuberculosis and Noncaseating Granulomas: Who Moved My Cheese
por: Dow, Coad Thomas, et al.
Publicado: (2023)

Tramadol-induced hiccups: a case–noncase study in the European pharmacovigilance database
por: García, Montserrat, et al.
Publicado: (2021)

Remdesivir and Mortality in Patients With Coronavirus Disease 2019
por: Diaz, George A, et al.
Publicado: (2021)

A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
por: Nevin, Remington L.
Publicado: (2017)

Adverse drug reactions and ivermectin in COVID-19
por: Montastruc, Jean-Louis
Publicado: (2022)

Cyclo‐oxygenase selectivity and chemical groups of nonsteroidal anti‐inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase
por: Bakhriansyah, Mohammad, et al.
Publicado: (2019)

Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection
por: Martinez, Mario A, et al.
Publicado: (2022)

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
por: Shih, Richard D., et al.
Publicado: (2020)

Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review
por: Yang, Chih-Jen, et al.
Publicado: (2021)

Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019
por: Igbinosa, Irogue, et al.
Publicado: (2020)

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
por: Burwick, Richard M, et al.
Publicado: (2020)

Remdesivir in Pregnant Patients with Novel Coronavirus Disease 2019: Case Series
por: Singh, Renu, et al.
Publicado: (2021)

Increased reporting of venous and arterial thromboembolic events reported with tixagevimab–cilgavimab for coronavirus disease 2019
por: Montastruc, François, et al.
Publicado: (2023)

Predicting serious rare adverse reactions of novel chemicals
por: Poleksic, Aleksandar, et al.
Publicado: (2018)

WITHDRAWN: Remdesivir investigational trials in coronavirus disease 2019: a critical reappraisal()()
por: Brouqui, P., et al.
Publicado: (2020)

Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
por: Lin, Hui Xian Jaime, et al.
Publicado: (2021)

The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review
por: Roshanshad, Amirhossein, et al.
Publicado: (2020)

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)
por: Pallotto, Carlo, et al.
Publicado: (2021)

Remdesivir for patients with Coronavirus disease 2019 pneumonia requiring high oxygen support
por: Alibrahim, Rim S., et al.
Publicado: (2022)

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
por: Garcia, Philippe, et al.
Publicado: (2020)

Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019
por: Louchet, Margaux, et al.
Publicado: (2020)

Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT)
por: Laroche, Marie‐Laure, et al.
Publicado: (2022)

Remdesivir: Infusion site reaction following extravasation of remdesivir: case report
Publicado: (2021)

A Case of Serious Adverse Reaction Following Rabies Vaccination
por: Kang, Zhilin, et al.
Publicado: (2018)

Noncaseating suppurative granulomatous lymphadenitis in adult onset Still’s disease – a diagnostic dilemma in a tuberculosis-endemic region: a case report
por: Chinthaka, S. W. G. J. W., et al.
Publicado: (2018)

Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)
por: Bennett, Charles L., et al.
Publicado: (2020)

Safety of Omalizumab During Pregnancy and Breast-Feeding With Assessment of Placental Transfer: A Case Report
por: Majou, Doriane, et al.
Publicado: (2020)

Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workers
por: Chouchana, Laurent, et al.
Publicado: (2022)

Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial
por: Defer, Gilles, et al.
Publicado: (2018)

Safety of Remdesivir for Patients 80 Years of Age or Older with Coronavirus Disease 2019 (COVID-19)
por: Kanai, Osamu, et al.
Publicado: (2021)

Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis
por: Sarfraz, Azza, et al.
Publicado: (2021)

Remdesivir-Induced Liver Injury in a Patient With Coronavirus Disease 2019 and History of Congestive Hepatopathy
por: Dividis, Georgios P, et al.
Publicado: (2022)

Remdesivir: Anaphylactic reaction: case report
Publicado: (2021)

Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
por: Thomsen, Henrik S.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_qgd04b36k70io6pnbpe35kdumh